Biotech

News

Elizabeth Holmes due to start prison sentence today

After years of legal wrangling, former Theranos chief executive Elizabeth Holmes is due to report later today at a federal prison, where she will start serving an 11-year

R&D

FT Live US Pharma and Biotech Summit 2023 - Day 2

For the second and final day of the FT US Pharma and Biotech Summit, day 2 kicks off with a session on cell and gene therapies.

R&D

FT Live US Pharma and Biotech Summit 2023 - Day 1

Here we are in the Big Apple for day 1 of the FT US Pharma and Biotech Summit.

R&D

FT Live US Pharma and Biotech Summit 2023

At the FT’s US Pharma and Biotech Summit in New York City, 16th and 17th May, leaders from across the pharma landscape will gather to discuss some of the hottest topics in US pharma, includ

News

Acelyrin raises $540 million in rare biotech IPO

Biotech watchers lamenting a fall-off in public listings for biotech companies will take some heart from Acelyrin’s upsized initial public offering, which ended up at the

R&D

Is biotech ready for the lecanemab opportunity?

The US Veterans Health Administration recently announced that it will cover the cost of Biogen’s lecanemab for veterans suffering from early stages of Alzheimer’s disease.